Posted by Michael Wonder on 06 Apr 2017
AusBiotech says R&D Tax Incentive critical to 2030 Innovation Strategy
6 April 2017 - Preserving the R&D Tax Incentive will be top priority as AusBiotech coordinates comment for Innovation and Science Australia’s consultation to develop a 2030 Strategic Plan for Australian innovation, science and its research system.
AusBiotech believes the destruction that will be caused if the proposed $2 million cap proceeds will seriously and immediately impact the Innovation and Science Australia (ISA) strategic plan.
AusBiotech members are invited to add comment to the industry’s submission as ISA seeks the views of key stakeholders to help develop the strategy in response to an Issues Paper.
The Issues Paper nominates six challenges that ISA sees as central to shaping the strategy, and suggests themes and questions for discussion.
